72
Participants
Start Date
April 30, 2014
Primary Completion Date
March 31, 2016
Study Completion Date
September 30, 2017
ANG1005
The Long Islan Brain Tumor Center at Neurological Surgery P.C., Commack
Magee Womens Hospital, Pittsburgh
UPMC Cancer Center, Pittsburgh
University of Maryland - Greenebaum Cancer Center, Baltimore
GRU Cancer Center - Georgia Regents University, Augusta
Cleveland Clinic, Cleveland
Cancer & Hematology Centers of Western Michigan, Grand Rapids
Northwestern University, Chicago
MD Anderson Cancer Center, Houston
Univeristy of Texas Health Science Center in San Antonio, San Antonio
University of Colorado Cancer Center, Aurora
University of Arizona Cancer Center, Tucson
University of New Mexico, Albuquerque
University of California - LAC Medical Center, Los Angeles
University of Southern California - Norris Comprehensive Cancer Center, Los Angeles
UC - Irvine Chao Family Comprehensive Cancer Center, Orange
UC San Diego Moores Cancer Center, La Jolla
National Cancer Institute, Bethesda
University of North Carolina at Chapel Hill, Chapel Hill
Lead Sponsor
Angiochem Inc
INDUSTRY